The 20 Best Hypercalcemia Doctors Near Me in Baltimore, MD

William Simonds is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Simonds is rated as an Elite provider by MediFind in the treatment of Hypercalcemia. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia, Parathyroid Adenoma, Parathyroidectomy, and Thymectomy. Dr. Simonds is board certified in American Board Of Internal Medicine.

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Hypercalcemia. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism. Dr. Kim is board certified in American Board Of Internal Medicine.

Sonum Bharill is a Pediatric Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Bharill is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. Her clinical expertise encompasses Hypercalcemia, Milk-Alkali Syndrome, Diabetic Ketoacidosis, and Type 1 Diabetes (T1D). Dr. Bharill is board certified in American Board Of Pediatrics.

Dr. Sara Mixter is Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are internal medicine, pediatrics, and primary care for adults with developmental disabilities and other complex childhood-onset conditions. She is the director of the Hopkins PACT (Pediatric-informed Adult Care and Transition) Clinic. Dr. Mixter is also the medical director of the Pediatric Complex Care Collaborative (PC3) for the Johns Hopkins Children’s Center. Dr. Mixter received her A.B. from Harvard College. She earned her M.D. from Harvard Medical School and M.P.H. from the Harvard School of Public Health. She completed her residency at Johns Hopkins as part of the inaugural group of trainees in the Urban Health Combined Internal Medicine-Pediatrics Residency Program. Her research interests include transitions of care for adolescents with special healthcare needs and education for residents and medical students, especially in primary care and complex care. Dr. Mixter has served as the Assistant Chief of Service for the Longcope firm of the Osler Medical Housestaff Training Program (2015-16), as well as Assistant Program Director for Ambulatory Education (2014-15). Dr. Mixter is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Cerebral Palsy, Gastroparesis, Orbital Cellulitis, and Sickle Cell Disease. Dr. Mixter is board certified in American Board Of Pediatrics and American Board Of Internal Medicine.

David S. Cooper, MD, MACP is a graduate of the Tufts University School of Medicine and completed his endocrinology training at Massachusetts General Hospital and Harvard Medical School. He is currently Professor of Medicine and Radiology at the Johns Hopkins University School of Medicine and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. He is one of the editors of the iconic textbook on thyroid disease, Werner and Ingbar’s The Thyroid, and he co-edits two other textbooks: Medical Management of Thyroid Disease and Thyroid Cancer. He is also the co-author of a book for patients with thyroid disease entitled Your Thyroid: A Home Reference. He is the past Chair of the Subspecialty Board for Endocrinology, Diabetes, and Metabolism of the American Board of Internal Medicine. He is an Editor-in-Chief for Endocrinology at Up-to-Date, and he has served as the Chair of the Endocrine Society’s annual Board Review Course. Dr. Cooper was the Chair of the American Thyroid Association’s (ATA) 2006 and 2009 task forces that first drafted clinical practice guidelines for the management of thyroid nodules and thyroid cancer. He also served on ATA sponsored task forces that promulgated guidelines for the management of hypothyroidism and for the management of hyperthyroidism. He is the past Treasurer and past President of the ATA, and the recipient of the ATA’s Distinguished Service Award, its Paul Starr Award, and the Lewis Braverman Lectureship Award. He is also the recipient of the Distinction in Endocrinology Award given by the American Association of Clinical Endocrinologists, as well as the Endocrine Society’s Outstanding Scholarly Physician Laureate Award and the Outstanding Educator Laureate Award. Dr. Cooper is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, and Medullary Thyroid Carcinoma. Dr. Cooper is board certified in American Board Of Internal Medicine.

Kristi Silver is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Silver is rated as an Advanced provider by MediFind in the treatment of Hypercalcemia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Thyroid Storm, Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D).

Hilary Whitlatch is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Whitlatch is rated as an Advanced provider by MediFind in the treatment of Hypercalcemia. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Rabson-Mendenhall Syndrome, Hyperparathyroidism, Osteoporosis, and Postmenopausal Osteoporosis.

Jeffrey Kroopnick is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Kroopnick is rated as an Advanced provider by MediFind in the treatment of Hypercalcemia. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Hypercalcemia, Milk-Alkali Syndrome, Type 2 Diabetes (T2D), and Familial Hypocalciuric Hypercalcemia Type 1.

Kashif Munir is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Munir is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Dr. Mohamad Hanouneh is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include renal medicine. Dr. Hanouneh grew up in Syria and completed his medical school in Tishreen University in Latakia, Syria. He completed Internal Medicine Residency training at Cleveland Clinic, and Nephrology Fellowship at Johns Hopkins. Dr. Hanouneh currently serves as a part-time faculty in the Division of Nephrology at Johns Hopkins. He also works in the Nephrology Center of Maryland covering Good Samaritan and Upper Chesapeake Hospitals. Dr. Hanouneh has a passion in medical education. He runs the nephrology board review course and participates in Genes to Society Course of Renal Physiology, which is given to the medical students at Johns Hopkins University School of Medicine. His area of interests are electrolytes disorders, diabetic kidney disease and nephrolithiasis. Dr. Hanouneh is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Low Potassium Level, End-Stage Renal Disease (ESRD), Chronic Kidney Disease, and High Potassium Level. Dr. Hanouneh is board certified in American Board Of Internal Medicine.

Malek Cheikh is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Cheikh is rated as an Advanced provider by MediFind in the treatment of Hypercalcemia. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Osteoporosis, and Postmenopausal Osteoporosis.

Colleen Leavitt, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians. She received her medical degree and completed her residency in medicine & pediatrics at Loyola University School of Medicine. Dr. Leavitt is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. Leavitt is board certified in American Board Of Pediatrics and American Board Of Internal Medicine.

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy. Dr. Zilbermint is board certified in American Board Of Internal Medicine.

Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Dr. Kendall Moseley is the Clinical Director of the Division of Diabetes, Endocrinology & Metabolism, Medical Director of the Johns Hopkins Metabolic Bone & Osteoporosis Center and Co-Director of the Johns Hopkins Multidisciplinary Parathyroid Clinic. Dr. Moseley received her medical degree from Baylor College of Medicine in Houston, TX, followed by internal medicine residency training at the Johns Hopkins Hospital. Upon completion of her endocrinology fellowship at Johns Hopkins, she joined the faculty in the Division of Endocrinology, Diabetes & Metabolism of the Johns Hopkins University School of Medicine. Dr. Moseley has a dynamic clinical practice and collaborations within the institution that focus on metabolic bone diseases, osteoporosis, hyperparathyroidism, vitamin D deficiency, atypical fractures, and skeletal survivorship. She is actively engaged in NIH-funded clinical and translational research involving the relationship between type 2 diabetes, osteoporosis, and aging. She is additionally involved in research investigating mechanisms by which chronic disease states such as malignancy, HIV, hepatitis C, and cystic fibrosis impact bone quantity and quality. Clinically, she enjoys partnering with her patients and using their unique and often complex medical history to individually tailor effective diet, lifestyle, and treatment regimens to improve skeletal health. Dr. Moseley is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Osteoporosis, Postmenopausal Osteoporosis, Paget's Disease of Bone, and Hyperparathyroidism.

Dr. Bernard Jaar is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include chronic kidney disease and all dialysis modalities. Dr. Jaar earned his M.D. from Faculte de Medecine et de Pharmacie of the State University of Haiti. He completed nephrology training at Hopitaux de Paris (Hopital Tenon, Hopital Saint Antoine, Hopital Saint Louis) University of Paris V, France. He subsequently completed an internal medicine residency at Graduate Hospital in Philadelphia and a nephrology fellowship at the Johns Hopkins Hospital, in addition to a post-doctoral fellowship in Epidemiology and a Master in Public Health at the Johns Hopkins Bloomberg School of Public Health. His research interests include epidemiology of chronic kidney disease and end-stage kidney disease, particularly survival in dialysis patients, peripheral arterial disease and environmental risk factors for kidney disease. Dr. Jaar was recognized with the C. Lockard Conley Award 2021 by the American College of Physician Maryland Chapter for contributions to resident education / research and the National Kidney Foundation Garabed Eknoyan Award 2022 for promoting the mission of NKF in making the lives of people with kidney disease better. He is a member of several professional organizations, including the International Society of Nephrology, American Society of Nephrology, National Kidney Foundation, American College of Physicians and the International Society of Peritoneal dialysis. Dr. Jaar is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Calcinosis, Nephrosclerosis, and Kidney Transplant. Dr. Jaar is board certified in American Board Of Internal Medicine.

Dr. Ronadip (Ron) Banerjee is an Associate Professor in the Division of Endocrinology, Diabetes and Metabolism at Johns Hopkins University School of Medicine. His clinical interests include Endocrine Tumors, such as Multiple Endocrine Neoplasia, adrenal tumors and disorders, pancreatic and neuroendocrine tumors, pituitary, thyroid and parathyroid disorders. Dr. Banerjee received his B.S. in Biological Sciences with. Dr. Banerjee is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia, Gestational Diabetes, and Adrenal Insufficiency Pediatric. Dr. Banerjee is board certified in American Board Of Internal Medicine.

Shadi Barakat is an Endocrinologist practicing medicine in Baltimore, Maryland. He has been practicing medicine for over 17 years. Dr. Barakat is rated as an Advanced provider by MediFind in the treatment of Hypercalcemia. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Toxic Nodular Goiter, Thyroid Cancer, and Thyroid Storm.

Marisha Newton is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Newton is rated as an Advanced provider by MediFind in the treatment of Hypercalcemia. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Familial Hypocalciuric Hypercalcemia Type 1, Idiopathic Hypercalciuria, Hypercalcemia, and Milk-Alkali Syndrome.

Dr. Luis F. Gimenez is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise includes nephrology. Dr. Gimenez received his medical degree from Facultad de Medicina de la Universidad de Chile. He completed residencies in internal medicine at Hospital Clinico Regional Dr. Guillermo Grant Benavente, Hospital Carlos Van Buren and the Johns Hopkins School of Medicine. He performed his fellowship in nephrology at Johns Hopkins. His research interests include the pathophysiology of chronic renal failure. Dr. Gimenez is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Acute Kidney Failure, and Minimal Change Disease. Dr. Gimenez is board certified in American Board Of Internal Medicine.